Hafnia alvei infection complicated by chorioamnionitis and septicemia: a case report and review of literature

• by Hong Wang, Hong Li, Haiyan Wang, Jin Zhang

• June 8, 2026

A preclinical randomised controlled dose optimization of megadose sodium ascorbate for reversal of gram-negative sepsis-induced cardiovascular, brain and kidney dysfunction

• by Connie Pei Chen Ow, Rachel M. Peiris, Anton Trask-Marino, Sally G. Hood, Ashenafi H. Betrie, Darius J. R. Lane, Rinaldo Bellomo, Mark P. Plummer, Clive N. May, Yugeesh R. Lankadeva

• December 28, 2025

FDA Approves Cefepime-Zidebactam Injection

Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.

• by Kathryn Wighton

• June 3, 2026

• 2 min

Discovery of a resistant cohort to acute kidney injury: insights from patients with septic shock

• by Dana Y. Fuhrman, Towia A. Libermann, Neil A. Hukriede, Luca Molinari, Samir M. Parikh, John A. Kellum

• October 8, 2025